# Quantitative Transmission Imaging Compared With MRI as Supplemental Screening for High Lifetime Risk of Breast Cancer

> **NCT07216274** · NA · COMPLETED · sponsor: **Mayo Clinic** · enrollment: 26 (actual)

## Conditions studied

- Breast Carcinoma

## Interventions

- **DEVICE:** QT Ultrasound Breast Scanner
- **OTHER:** Questionnaire Administration

## Key facts

- **NCT ID:** NCT07216274
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2025-07-31
- **Primary completion:** 2025-10-20
- **Final completion:** 2025-10-20
- **Target enrollment:** 26 (ACTUAL)
- **Last updated:** 2025-12-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07216274

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07216274, "Quantitative Transmission Imaging Compared With MRI as Supplemental Screening for High Lifetime Risk of Breast Cancer". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT07216274. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*